A person's type D personality and hypothyroidism may make them more susceptible to unfavorable treatment results.

Published Date: 10 Apr 2024

People with hypothyroidism have a high prevalence of type D personality, according to new research published in The Journal of Clinical Endocrinology and Metabolism. The article is headed "Outcomes of Hypothyroidism and Type D Personality.".

Read Full News

Latest News

4D CT Aids Parathyroid Adenoma Localisation, Lateralisation

Multiphase '4D' CT offers reliable diagnostic accuracy for localising parathyroid adenomas when first-line nuclear medicine imaging and ultrasound yield negative or discordant results.

Increased Coffee Intake May Lower Liver Disease Risk

Higher coffee consumption is associated with better liver outcomes than no coffee consumption, a recent study finds.

Could Childhood Obesity Risk Begin Before Birth?

Emerging evidence links prenatal biology and early-life exposures to later obesity risk, suggesting that prevention may need to begin before excess weight develops.

Novonesis Expects Results From Weight-loss Drug Supplement Study in 2027

Danish biosolutions maker Novonesis expects results in the second half of 2027 from research ⁠with Novo Nordisk into whether microbiome supplements could provide additional...

Prepubertal T1D Onset Tied to Lower Risk for Complications

Children diagnosed with T1D before age 7 may face a lower risk for long-term chronic complications in the first 20 years post-diagnosis than those diagnosed later in childhood.

Celon Pharma's Generic Semaglutide Drug Matches Ozempic in Early Study, Shares Jump

Celon Pharma's experimental semaglutide product Reduzek, a generic alternative ⁠to Novo Nordisk's Wegovy and Ozempic, matched the blockbuster weight-loss ⁠drugs in an...

Todays Updates

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

In 20 Different Cancers, Men More Likely to Be Diagnosed at a Later Stage

More late-stage diagnoses add to higher cancer mortality burden for men

Guidelines Help Spot Dermatomyositis Patients at High Risk for Cancer

IMACS guidelines are clinically useful for identifying high-risk populations, researchers say

Viral NeeDoh Trend Leading to Scalding Injuries, Doctors Warn

Kids are microwaving the squishy toy, making the gel inside hot enough to boil and explode

What Is the 'Barbie Peptide' and Why Is It Risky?

Dermatologists weigh in on the injectable trend

Fauci's Diaries Released; Cold Brew Recalled; Carly Simon's Diagnosis

Health news and commentary gathered by MedPage Today staff

FDA Staff Unconvinced Drug for Melanoma Shows Benefit

Replimune's RP1 faces tough test at upcoming FDA advisory panel meeting

Todays Updates

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

In 20 Different Cancers, Men More Likely to Be Diagnosed at a Later Stage

More late-stage diagnoses add to higher cancer mortality burden for men

Guidelines Help Spot Dermatomyositis Patients at High Risk for Cancer

IMACS guidelines are clinically useful for identifying high-risk populations, researchers say

Viral NeeDoh Trend Leading to Scalding Injuries, Doctors Warn

Kids are microwaving the squishy toy, making the gel inside hot enough to boil and explode

What Is the 'Barbie Peptide' and Why Is It Risky?

Dermatologists weigh in on the injectable trend

Fauci's Diaries Released; Cold Brew Recalled; Carly Simon's Diagnosis

Health news and commentary gathered by MedPage Today staff

FDA Staff Unconvinced Drug for Melanoma Shows Benefit

Replimune's RP1 faces tough test at upcoming FDA advisory panel meeting

Latest News

Multiphase '4D' CT offers reliable diagnostic accuracy for localising parathyroid adenomas when first-line nuclear medicine imaging and ultrasound yield negative or discordant results.

Higher coffee consumption is associated with better liver outcomes than no coffee consumption, a recent study finds.

Emerging evidence links prenatal biology and early-life exposures to later obesity risk, suggesting that prevention may need to begin before excess weight develops.

Danish biosolutions maker Novonesis expects results in the second half of 2027 from research ⁠with Novo Nordisk into whether microbiome supplements could provide additional...

Children diagnosed with T1D before age 7 may face a lower risk for long-term chronic complications in the first 20 years post-diagnosis than those diagnosed later in childhood.

Celon Pharma's experimental semaglutide product Reduzek, a generic alternative ⁠to Novo Nordisk's Wegovy and Ozempic, matched the blockbuster weight-loss ⁠drugs in an...

News All Time

Novo Begins Study to Find Lowest Effective Dose for Wegovy Pill

Danish drugmaker Novo Nordisk is testing smaller doses of its Wegovy pill in a new late-stage study to find the lowest ⁠dose that would still help patients lose weight,...

Prior GLP-1 Use Doesn’t Affect Bariatric Surgery Results

Patients who have and have not had prior GLP-1 treatment show similar levels of weight loss with bariatric surgery.

Screening for Confidence Tailors GLP-1 Care

Perceived competence — not other factors — best distinguishes weight-loss success with GLP-1 treatment.

Amylyx Drug Cuts Low Blood Sugar Episodes in Bariatric Surgery Patients in Key Trial

Amylyx Pharmaceuticals' experimental drug sharply reduced dangerously low blood sugar episodes in a late-stage trial of patients who ⁠underwent weight-loss surgery, sending...

Diabetes Drug Curbs Weight Gain in Older People With HIV

Metformin, a common diabetes drug, curbs weight gain in older people with HIV over 96 weeks, but the effect reverses after treatment stops, a trial finds.

Semaglutide and Depression: No Clear Link Found

A meta-analysis finds no significant association between use of semaglutide and risk for depression, although with limited certainty of evidence.

GI Medicine Is a ‘Fantastic Voyage’: AGA President Cryer

Gastroenterologist Byron L. Cryer, MD, discusses mentorship, NSAID research, difficult patient conversations, and why access to care remains a pressing challenge.

Swapping Soda for Diet Drinks May Not Cut T2D Risk

Swapping sugary drinks for diet drinks is linked to an increased risk for type 2 diabetes, particularly among younger adults and those of non-Dutch origin.

Low-Carb Diet Tied to Healthier Target Weight

In women with overweight or obesity, eating lower carbs is linked to a healthier target weight and lower waist circumference, body fat, and visceral fat but not to the A Body Shape Index.

CGM Metrics Can Improve Prognosis Insights Beyond A1c in T1D

In patients with T1D, certain CGM metrics can provide information on the risk for severe hypoglycemia independent of A1c and add predictive value for diabetic ketoacidosis.

Health Round: Most Air Pollution Exposure in U.S. Pregnancies Is From Wildfires, Study Says

We also share a report from cardiologists that suggests you might (or might not) want to check your waist and hip measurements, and a laboratory study with some encouraging...

Prader-Willi Experts Flag Safety Risks Linked to Rare Disease Drug

Experts in Prader-Willi Syndrome on Tuesday raised safety concerns over Neurocrine's drug Vykat XR, citing serious adverse events reported ⁠in patients with the rare genetic...

Duration and Age Tied to Different Complication Risks in T1D

In patients with childhood onset T1D, a longer diabetes duration is mainly linked to a higher risk for retinopathy, and older age more strongly predicts albuminuria after over 30 years of follow up.

Role-Play as Patients Helps Docs Manage Diabetes Better

A 1-week, on-site role-play-based program in which physicians simulate patient experiences leads to better A1c control in patients with type 2 diabetes at 6 and 12 months.

Weekly Somapacitan Effective and Safe in Turner Syndrome

Once-weekly somapacitan is as effective as daily growth hormone in promoting linear growth among treatment-naive girls with Turner syndrome, offering a suitable alternative treatment.

Med Op-Ed: Drugs, Obesity, and BMI at a Crossroads

Should the FDA rein in celebrity drug endorsements? Could redefining obesity end up rationing care? And is relying on BMI alone letting patients down?

Recommended News For You

AI-based liquid biopsy shows promise for detecting brain cancer

The importance of breast cancer screening

Belgian Algorithm Reshapes Endometrial Cancer Care

Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

Similar survival seen with simple versus radical hysterectomy for cervical cancer

Recommended Articles For You

The Benefits of Understanding Haptoglobin High: What You Need to Know 

How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases? 

Advancements in Cancer Treatment and Survival Outcomes for Acute Myeloid Leukemia 

Unmasking the Hidden Symptoms of Ovarian Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

2.

Even a few mutated cells can significantly impact how blood cancers develop, study finds

3.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

4.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

5.

In Acute Leukemia With Heavily Pretreated Patients, Menin Inhibitor Yields 63 Percent ORR.

1.

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease 

2.

First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care

3.

Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions

4.

Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management

5.

Fc Receptor Mediated Pharmacology of Therapeutic Antibodies

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Oropharyngeal Cancer in Relation to HPV Status

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

4.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

5.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot